Summary

HNY Research projects that the Hydroxycarbamide market size will grow from 264.42 Million USD in 2025 to 382.54 Million USD by 2031, at an estimated CAGR of 6.35%. The base year considered for the study is 2025, and the market size is projected from 2026 to 2031.
For 2025 regional market size, the North America market size was 51.88 Million USD, the Europe market size was 48.02 Million USD, and the Asia market size was 45.32 Million USD.
This report presents a detailed and holistic analysis of the global Hydroxycarbamide market. It integrates quantitative data with qualitative insights to equip readers with the necessary information for strategic planning, competitive assessment, market positioning, and data-driven decision-making.
All market sizes, estimates, and forecasts are expressed in terms of output/shipments and revenue. With 2025 serving as the base year, the report provides historical context from 2020. and projections up to 2031. It includes a complete segmentation of the global market, along with regional market sizes analyzed by type, application, and key industry participants.
Further enriching the analysis, the report outlines the competitive environment, offering profiles of prominent players and their market standings. It also explores key technological advancements and recent developments in product offerings.
Ultimately, this report serves as a vital resource for Hydroxycarbamide manufacturers, prospective entrants, and other stakeholders within the industry value chain. It supplies comprehensive data on revenues, production, and average pricing for the overall market and its sub-segments, detailed by company, product type, application, and geographic region.

By Market Players:
Bristol Myers Squibb
Taj Pharma
Beijing Jialin Pharma
Qilu Pharmaceutical
Teva Pharma
Cipla
Zydus Cadila
United Biotech
Par Pharma
Khandelwal Laboratories
Alkem (Cytomed)
Samarth Pharma
VHB Life Sciences

By Type
Capsule
Tablet

By Application
Sickle Cell Disease
Cancer
Others

By Regions/Countries:
North America
East Asia
Europe
South Asia
Southeast Asia
Middle East
Africa
Oceania
South America

Points Covered in The Report
The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.
The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years data history and forecast.
The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.
Data and information by market player, by region, by type, by application and etc, and custom research can be added according to specific requirements.
The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

ページTOPに戻る

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hydroxycarbamide Revenue
1.4 Market Analysis by Type
1.4.1 Global Hydroxycarbamide Market Size Growth Rate by Type: 2026-2031
1.4.2 Capsule
1.4.3 Tablet
1.5 Market by Application
1.5.1 Global Hydroxycarbamide Market Share by Application: 2026-2031
1.5.2 Sickle Cell Disease
1.5.3 Cancer
1.5.4 Others
1.6 Study Objectives
1.7 Overview of Global Hydroxycarbamide Market
1.7.1 Global Hydroxycarbamide Market Status and Outlook (2020-2031)
1.7.2 North America
1.7.3 East Asia
1.7.4 Europe
1.7.5 South Asia
1.7.6 Southeast Asia
1.7.7 Middle East
1.7.8 Africa
1.7.9 Oceania
1.7.10 South America
1.7.11 Rest of the World
2 Manufacturing Cost Structure Analysis
2.1 Manufacturing Cost Structure Analysis of Hydroxycarbamide
2.2 Industry Chain Structure of Hydroxycarbamide
3 Market Competition by Manufacturers
3.1 Global Hydroxycarbamide Production Capacity Market Share by Manufacturers (2020-2025)
3.2 Global Hydroxycarbamide Revenue Market Share by Manufacturers (2020-2025)
3.3 Global Hydroxycarbamide Average Price by Manufacturers (2020-2025)
4 Hydroxycarbamide Regional Market Analysis
4.1 Hydroxycarbamide Production by Regions
4.1.1 Global Hydroxycarbamide Production by Regions (2020-2025)
4.1.2 Global Hydroxycarbamide Revenue by Regions
4.2 Hydroxycarbamide Consumption by Regions
4.3 North America Hydroxycarbamide Market Analysis
4.3.1 North America Hydroxycarbamide Production
4.3.2 North America Hydroxycarbamide Revenue
4.3.3 Key Manufacturers in North America
4.3.4 North America Hydroxycarbamide Import and Export
4.4 East Asia Hydroxycarbamide Market Analysis
4.4.1 East Asia Hydroxycarbamide Production
4.4.2 East Asia Hydroxycarbamide Revenue
4.4.3 Key Manufacturers in East Asia
4.4.4 East Asia Hydroxycarbamide Import & Export
4.5 Europe Hydroxycarbamide Market Analysis
4.5.1 Europe Hydroxycarbamide Production
4.5.2 Europe Hydroxycarbamide Revenue
4.5.3 Key Manufacturers in Europe
4.5.4 Europe Hydroxycarbamide Import & Export
4.6 South Asia Hydroxycarbamide Market Analysis
4.6.1 South Asia Hydroxycarbamide Production
4.6.2 South Asia Hydroxycarbamide Revenue
4.6.3 Key Manufacturers in South Asia
4.6.4 South Asia Hydroxycarbamide Import & Export
4.7 Southeast Asia Hydroxycarbamide Market Analysis
4.7.1 Southeast Asia Hydroxycarbamide Production
4.7.2 Southeast Asia Hydroxycarbamide Revenue
4.7.3 Key Manufacturers in Southeast Asia
4.7.4 Southeast Asia Hydroxycarbamide Import & Export
4.8 Middle East Hydroxycarbamide Market Analysis
4.8.1 Middle East Hydroxycarbamide Production
4.8.2 Middle East Hydroxycarbamide Revenue
4.8.3 Key Manufacturers in Middle East
4.8.4 Middle East Hydroxycarbamide Import & Export
4.9 Africa Hydroxycarbamide Market Analysis
4.9.1 Africa Hydroxycarbamide Production
4.9.2 Africa Hydroxycarbamide Revenue
4.9.3 Key Manufacturers in Africa
4.9.4 Africa Hydroxycarbamide Import & Export
4.10 Oceania Hydroxycarbamide Market Analysis
4.10.1 Oceania Hydroxycarbamide Production
4.10.2 Oceania Hydroxycarbamide Revenue
4.10.3 Key Manufacturers in Oceania
4.10.4 Oceania Hydroxycarbamide Import & Export
4.11 South America Hydroxycarbamide Market Analysis
4.11.1 South America Hydroxycarbamide Production
4.11.2 South America Hydroxycarbamide Revenue
4.11.3 Key Manufacturers in South America
4.11.4 South America Hydroxycarbamide Import & Export
5 Hydroxycarbamide Sales Market by Type (2020-2031)
5.1 Global Hydroxycarbamide Historic Market Size by Type (2020-2025)
5.2 Global Hydroxycarbamide Forecasted Market Size by Type (2026-2031)
6 Hydroxycarbamide Consumption Market by Application(2020-2031)
6.1 Global Hydroxycarbamide Historic Market Size by Application (2020-2025)
6.2 Global Hydroxycarbamide Forecasted Market Size by Application (2026-2031)
7 Company Profiles and Key Figures in Hydroxycarbamide Business
7.1 Bristol Myers Squibb
7.1.1 Bristol Myers Squibb Company Profile
7.1.2 Bristol Myers Squibb Hydroxycarbamide Product Specification
7.1.3 Bristol Myers Squibb Hydroxycarbamide Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.2 Taj Pharma
7.2.1 Taj Pharma Company Profile
7.2.2 Taj Pharma Hydroxycarbamide Product Specification
7.2.3 Taj Pharma Hydroxycarbamide Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.3 Beijing Jialin Pharma
7.3.1 Beijing Jialin Pharma Company Profile
7.3.2 Beijing Jialin Pharma Hydroxycarbamide Product Specification
7.3.3 Beijing Jialin Pharma Hydroxycarbamide Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.4 Qilu Pharmaceutical
7.4.1 Qilu Pharmaceutical Company Profile
7.4.2 Qilu Pharmaceutical Hydroxycarbamide Product Specification
7.4.3 Qilu Pharmaceutical Hydroxycarbamide Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.5 Teva Pharma
7.5.1 Teva Pharma Company Profile
7.5.2 Teva Pharma Hydroxycarbamide Product Specification
7.5.3 Teva Pharma Hydroxycarbamide Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.6 Cipla
7.6.1 Cipla Company Profile
7.6.2 Cipla Hydroxycarbamide Product Specification
7.6.3 Cipla Hydroxycarbamide Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.7 Zydus Cadila
7.7.1 Zydus Cadila Company Profile
7.7.2 Zydus Cadila Hydroxycarbamide Product Specification
7.7.3 Zydus Cadila Hydroxycarbamide Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.8 United Biotech
7.8.1 United Biotech Company Profile
7.8.2 United Biotech Hydroxycarbamide Product Specification
7.8.3 United Biotech Hydroxycarbamide Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.9 Par Pharma
7.9.1 Par Pharma Company Profile
7.9.2 Par Pharma Hydroxycarbamide Product Specification
7.9.3 Par Pharma Hydroxycarbamide Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.10 Khandelwal Laboratories
7.10.1 Khandelwal Laboratories Company Profile
7.10.2 Khandelwal Laboratories Hydroxycarbamide Product Specification
7.10.3 Khandelwal Laboratories Hydroxycarbamide Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.11 Alkem (Cytomed)
7.11.1 Alkem (Cytomed) Company Profile
7.11.2 Alkem (Cytomed) Hydroxycarbamide Product Specification
7.11.3 Alkem (Cytomed) Hydroxycarbamide Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.12 Samarth Pharma
7.12.1 Samarth Pharma Company Profile
7.12.2 Samarth Pharma Hydroxycarbamide Product Specification
7.12.3 Samarth Pharma Hydroxycarbamide Production Capacity, Revenue, Price and Gross Margin (2020-2025)
7.13 VHB Life Sciences
7.13.1 VHB Life Sciences Company Profile
7.13.2 VHB Life Sciences Hydroxycarbamide Product Specification
7.13.3 VHB Life Sciences Hydroxycarbamide Production Capacity, Revenue, Price and Gross Margin (2020-2025)
8 Production and Supply Forecast
8.1 Global Forecasted Production of Hydroxycarbamide (2026-2031)
8.2 Global Forecasted Revenue of Hydroxycarbamide (2026-2031)
8.3 Global Forecasted Price of Hydroxycarbamide (2020-2031)
8.4 Global Forecasted Production of Hydroxycarbamide by Region (2026-2031)
8.4.1 North America Hydroxycarbamide Production, Revenue Forecast (2026-2031)
8.4.2 East Asia Hydroxycarbamide Production, Revenue Forecast (2026-2031)
8.4.3 Europe Hydroxycarbamide Production, Revenue Forecast (2026-2031)
8.4.4 South Asia Hydroxycarbamide Production, Revenue Forecast (2026-2031)
8.4.5 Southeast Asia Hydroxycarbamide Production, Revenue Forecast (2026-2031)
8.4.6 Middle East Hydroxycarbamide Production, Revenue Forecast (2026-2031)
8.4.7 Africa Hydroxycarbamide Production, Revenue Forecast (2026-2031)
8.4.8 Oceania Hydroxycarbamide Production, Revenue Forecast (2026-2031)
8.4.9 South America Hydroxycarbamide Production, Revenue Forecast (2026-2031)
8.4.10 Rest of the World Hydroxycarbamide Production, Revenue Forecast (2026-2031)
8.5 Forecast by Type and by Application (2026-2031)
8.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2026-2031)
8.5.2 Global Forecasted Consumption of Hydroxycarbamide by Application (2026-2031)
9 Consumption and Demand Forecast
9.1 North America Forecasted Consumption of Hydroxycarbamide by Country
9.2 East Asia Market Forecasted Consumption of Hydroxycarbamide by Country
9.3 Europe Market Forecasted Consumption of Hydroxycarbamide by Countriy
9.4 South Asia Forecasted Consumption of Hydroxycarbamide by Country
9.5 Southeast Asia Forecasted Consumption of Hydroxycarbamide by Country
9.6 Middle East Forecasted Consumption of Hydroxycarbamide by Country
9.7 Africa Forecasted Consumption of Hydroxycarbamide by Country
9.8 Oceania Forecasted Consumption of Hydroxycarbamide by Country
9.9 South America Forecasted Consumption of Hydroxycarbamide by Country
9.10 Rest of the world Forecasted Consumption of Hydroxycarbamide by Country
10 Marketing Channel, Distributors and Customers
10.1 Marketing Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities and Drivers
11.3 Challenges
11.4 Porter's Five Forces Analysis
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer